Thomas Merdan
Impact in
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- Nanoparticle-Based Drug Delivery 5
- Genetics 8
- Virus-based gene therapy research 8
- Co-authors
- Thomas Kissel (14 shared papers)Jindŕich Kopec̆ek (4 shared papers)Klaus Kunath (5 shared papers)Xintao Shuai (3 shared papers)Holger Petersen (4 shared papers)Udo Bakowsky (4 shared papers)Florian Tobias Unger (3 shared papers)Dagmar Fischer (3 shared papers)
- Journals
- Bioconjugate Chemistry (7 papers)Journal of Controlled Release (2 papers)The Journal of Gene Medicine (1 paper)Advanced Drug Delivery Reviews (1 paper)Macromolecules (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Thomas Merdan
21 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 105
- Biomaterials 807
- Pharmaceutical Science 196
- Molecular Biology 1.9k
- Genetics 611
- Polymers and Plastics 274
Countries citing papers authored by Thomas Merdan
This map shows the geographic impact of Thomas Merdan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Merdan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Merdan more than expected).
Fields of papers citing papers by Thomas Merdan
This network shows the impact of papers produced by Thomas Merdan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Merdan. The network helps show where Thomas Merdan may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Merdan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 698 | |
| 2 | 2004 | 309 | |
| 3 | 2005 | 221 | |
| 4 | 2003 | 201 | |
| 5 | 2003 | 160 | |
| 6 | 2002 | 133 | |
| 7 | 2003 | 131 | |
| 8 | 2002 | 117 | |
| 9 | 2007 | 113 | |
| 10 | 2005 | 97 | |
| 11 | 2002 | 85 | |
| 12 | 2009 | 81 | |
| 13 | 2022 | 72 | |
| 14 | 2006 | 58 | |
| 15 | 2008 | 54 | |
| 16 | 2004 | 54 | |
| 17 | 2007 | 40 | |
| 18 | 2009 | 37 | |
| 19 | 2004 | 36 | |
| 20 | 2023 | 21 |
About Thomas Merdan
Thomas Merdan is a scholar working on Biomaterials, Genetics, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 21 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (15 papers), Virus-based gene therapy research (8 papers), Advanced biosensing and bioanalysis techniques (8 papers), Nanoparticle-Based Drug Delivery (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cell Adhesion Molecules Research (2 papers), Advanced Drug Delivery Systems (2 papers) and Advanced Polymer Synthesis and Characterization (2 papers). The work is most often cited by research in Biomaterials (807 citations), Pharmaceutical Science (196 citations), Molecular Biology (1.9k citations), Genetics (611 citations) and Polymers and Plastics (274 citations). Thomas Merdan has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Thomas Kissel, Jindŕich Kopec̆ek, Klaus Kunath, Xintao Shuai, Holger Petersen, Udo Bakowsky, Florian Tobias Unger, Dagmar Fischer, Fu Xi and Andreas Schaper. Their work appears in journals such as Bioconjugate Chemistry, Journal of Controlled Release, The Journal of Gene Medicine, Advanced Drug Delivery Reviews and Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.